Atazanavir-associated choledocholithiasis leading to acute hepatitis in an HIV-infected adult

Annals of Pharmacotherapy

Volumn 44, Issue 1, 2010, Pages 202-206

  Jacques, Amanda Caroline ^a   Giguère, Pierre ^b   Zhang, Guijun ^c   Touchie, Claire ^d   La Porte, Charles J L ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Atazanavir; Choledocholithiasis; Cholelithiasis; HIV; Hyperbilirubinemia

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ATAZANAVIR; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLECYSTECTOMY; COMMON BILE DUCT STONE; EPIGASTRIC PAIN; FEMALE; HEMATEMESIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; NAUSEA; PRIORITY JOURNAL;

ACUTE DISEASE; CHOLEDOCHOLITHIASIS; FEMALE; GALLSTONES; HEPATITIS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LIVER; MIDDLE AGED; OLIGOPEPTIDES; PYRIDINES;

EID: 74549217021     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M489     Document Type: Article

References (18)

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 - infected adults and adolescents. Department of Health and Human Services. November 3, 2008;pp 1-139. http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf (accessed 2009 Aug 12).
2. Product monograph. Reyataz (atazanavir). Montreal, QC: Bristol-Myers Squibb, May 2007.
3. Zhang D, Chando TJ, Everett DW, Patten CJ, Dehal SS, Humphreys WG. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation. Drug Metab Dispos 2005;33:1729-39.
4. Lankisch TO, Moebius U, Wehmeier M, et al. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype. Hepatology 2006;44:1324-32.
5. Smith D, Jeganathan S, Ray J. Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations. HIV Clin Trials 2006;7:34-8.
6. Lorello G, la Porte C, Pilon R, Zhang G, Karnauchow T, MacPherson P. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma. HIV Med 2009;10:548-54.
7. Kevin MK, Paul DB. Hyperbilirubinemia in the setting of antiviral therapy. Clin Gastroenterol Hepatol 2005;3:303-10.
8. Greenberger NJ, Paugmarter G. Diseases of the gallbladder and bile ducts. In: Fauci AS, Braunwald E, Kasper DL, et al., eds. Harrison's online. New York: McGraw-Hill. www.harrisonsonline.com (accessed 2009 Jun 25).
9. Erlinger S. Drug-induced cholestasis. J Hepatol 1997;26:1-4.
10. Siveke JÂT, Bogner JÂR. Cholelithiasis possibly induced by protease inhibitors in 3 patients. Clin Infect Dis 2003;36:1498-500.
11. Verdon R, Daudon M, Albessard F, Brefort J-L, Bazin C. Indinavir-induced cholelithiasis in a patient infected with human immunodeficiency virus. Clin Infect Dis 2002;35:e57-9.
12. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
13. Mohiuddin R, Lewis JH. Drug- and chemical-induced cholestasis. Clin Liver Dis 2004;8:95-132.
14. Morgan DH. Jaundice associated with amitriptyline. Br J Psychiatry 1969;115:105-6.
15. Randeva H, Bangar V, Sailesh S, et al. Fatal cholestatic jaundice associated with amitriptyline. Int J Clin Pract 2000;54:405-6.
16. Uchaipichat V, Mackenzie PI, Elliot DJ, Miners JO. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human UDP-glucuronosyltransferases. Drug Metab Dispos 2006;34:449-56.
17. Product monograph. Effexor XR capsules (venlafaxine). Montreal, QC: Wyeth Canada, March 2009.
18. Product monograph. Kivexa (abacavir). Mississauga, ON: GlaxoSmith-Kline Shire Canada, December 2008.